Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: A pilot study

Drugs of Today

Volumn 41, Issue 7, 2005, Pages 453-459

  Karimi, Ouafae ^a   Peña, A Salvador ^a   Van Bodegraven, Adriaan A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; PILOT STUDY; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; ULCERATIVE COLITIS; VISUAL ANALOG SCALE;

ADULT; ARTHRALGIA; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS;

EID: 26844552930     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2005.41.7.917341     Document Type: Article

References (41)

1. Orchard, T.R., Wordsworth, B.P., Jewell, D.P. Peripheral arthropathies in inflammatory bowel disease: Their articular distribution and natural history. Gut 1998, 42: 387-91.
2. Brynskov, J., Binder, V. Arthritis and the gut. Eur J Gastroenterol Hepatol 1999, 11: 9979.
3. Gravallese, E.M., Kantrowitz, F.G. Arthritic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988, 83: 703-9.
4. Thomas, P.D., Keat, A.C., Forbes, A., Ciclitira, P.J., Nicholls, R.J. Extraintestinal manifestations of ulcerative colitis following restorative proctocolectomy. Eur J Gastroenterol Hepatol 1999, 11: 1001-5.
5. Leirisalo-Repo, M., Repo, H. Gut and spondyloanthropathies. Rheum Dis Clin North Am 1992, 18: 23-35.
6. Hermann, E. T cells in reactive arthritis. Apmis 1993, 101: 177-86.
7. Leirisalo-Repo, M., Suoranta, H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum 1988, 31: 533-7.
8. Mattila, L., Leirisalo-Repo, M., Koskimies, S., Granfors, K., Sütonen, A. Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 1994, 33: 1136-41.
9. Seager, K., Bashir, H.V., Geczy, A.F., Edmonds, J., de Vere-Tyndall, A. Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979, 277: 68-70.
10. Geczy, A.F., Alexander, K., Bashir, H.V., Edmonds, J. A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component. Nature 1980, 283: 782-4.
11. Picco, P., Gattorno, M., Marchese, N. et al. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters. Clin Exp Rheumatol 2000, 18: 773-8.
12. Lahesmaa, R., Skurnik, M., Vaara, M. et al. Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1helix. Clin Exp Immunol 1991, 86: 399-404.
13. Cuvelier, C.A., Quatacker, J., Mielants, H., De Vos, M., Veys, E., Roels, H.J. M-cells are damaged and increased in number in inflamed human ileal mucosa. Histopathology 1994, 24: 417-26.
14. Soderholm, J.D., Peterson, K.H., Olaison, G. et al. Epithelial permeability to proteins in the non-inflamed ileum of Crohn's disease? Gastroenterology 1999, 117: 65-72.
15. Hermann, E., Ackermann, B., Duchmann, R., Meyer zum Buschenfelde, K.H. Synovial fluid MHC-unrestricted gamma delta-T lymphocytes contribute to antibacterial and antiself cytotoxicity in the spondylarthropathies. Clin Exp Rheumatol 1995, 13: 187-91.
16. Hermann, E., Fleischer, B., Meyer zum Buschenfelde, K.H. Bacteria-specific cytotoxic CDB+ T cells: A missing link in the pathogenesis of the HL A-B27-associated spondylarthropathies. Ann Med 1994, 26: 365-9.
17. Hermann, E., Yu, D.T., Meyer zum Buschenfelde, K.H., Fleischer, B. HLA-B27-restricted CDS T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993, 342: 646-50.
18. Van Bodegraven, A.A., Pena, A.S. Treatment of extraintestinal manifestations in inflammatory bowel disease. Curr Treat Options Gastroenterol 2003, 6: 201-12.
19. Topol, E.J. Arthritis medicines and cardiovascular events - "House of Coxibs" (Editorial). JAMA 2005, 293: 366-368.
20. Hennan, J.K., Huang, J., Barrett, T.D. et al. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation 2001, 104: 820-5.
21. Lennard-Jones, J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170: 2-6; discussion 16-9.
22. Truelove, S.C., Witts, L.J. Cortisone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 1955, (4947): 1041-8.
23. Harvey, R.F., Bradshaw, J.M. A simple index of Crohn's-disease activity. Lancet 1980, 1: 514.
24. Ritchie, D.M., Boyle, J.A., McInnes, J.M. et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968, 37: 393-406.
25. Gionchetti, P., Rizzello, F., Venturi, A. et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterology 2000, 119: 305-9.
26. Karimi, O., Pena, A.S. Probiotics: Isolated bacteria strain or mixtures of different strains? Two different approaches in the use of probiotics as therapeutics. Drugs of Today 2003, 39: 565-97.
27. Adolfsson, O., Meydani, S.N., Russell, R.M. Yogurt and gut function. Am J Clin Nutr 2004, 80: 245-56.
28. Madsen, K., Cornish, A., Soper, P. et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 1-21: 580-91.
29. Isolauri, E., Kaila, M., Arvola, T. et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993, 33: 548-53.
30. Madsen, K.L., Malfair, D., Gray, D., Doyle, J.S., Jewell, L.D., Fedorak, R.N. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 1999, 5: 262-70.
31. Ulisse, S., Gionchetti, P., D'Alo, S. et al. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment. Am J Gastroenterol 2001, 96: 2691-9.
32. Petrof, E.O., Kojima, K., Ropelski, M.J., Musch, M.W. Probiotics inhibit NF-κB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004, 127: 1474-87.
33. Korhonen, R., Kosonen, O., Korpela, R., Moilanen, E. The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett Appl Microbiol 2004, 39: 19-24.
34. Aabakken, L., Osnes, M. Non-steroidal anti-inflammatory drug-induced disease in the distal ileum and large bowel. Scand J Gastroenterol Suppl 1989, 163: 48-55.
35. Hayllar, J., Bjarnason, I. NSAIDs, Cox-2 inhibitors, and the gut. Lancet 1995, 346: 521-2.
36. Newberry, R.D., Stenson, W.F., Lorenz, R.G. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999, 5: 900-6.
37. Hatakka, K., Martio, J., Korpela, M. et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003, 32: 2115.
38. Baharav, E., Mor, F., Halpern, M., Weinberger, A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 2004, 134: 1964-9.
39. Shell, B., McCarthy, J., O'Mahony, L. et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004, 53: 694-700.
40. Borriello, S.P., Hammes, W.P., Holzapfel, W. et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003, 36: 775-80.
41. Fedorak, R.N., Madsen, K.L. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004, 10: 286-99.